Welcome to our dedicated page for Sleep Number SEC filings (Ticker: SNBR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sleep Number Corporation SEC filings document its personalized sleep-products business, capital structure and public-company governance. Form 8-K disclosures cover operating results, Regulation FD investor presentations, amendments to its credit agreement, covenant and liquidity terms, financing arrangements, officer appointments, board changes and compensatory arrangements.
The company’s proxy materials describe director matters, executive compensation, equity awards and shareholder voting items. Together, the filings provide formal records for Sleep Number’s direct-to-consumer retail model, product and marketing strategy, debt obligations, internal reporting roles and governance practices.
Sleep Number Corporation reported the results of its 2026 Annual Meeting of Shareholders. Investors approved an amendment to the 2020 Equity Incentive Plan, increasing the shares reserved for issuance by 750,000 shares, and this amendment is filed as Exhibit 10.1.
Shareholders elected three directors, ratified Deloitte & Touche LLP as auditor, and approved the advisory vote on executive compensation. Governance proposals to declassify the Board and eliminate certain supermajority voting requirements received strong support but did not reach the required two-thirds of outstanding shares, so those changes were not adopted.
Eyler Phillip reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp director Phillip Eyler reported an equity award of 15,067 shares of common stock, received as a grant at no cost. This award appears in the filing as restricted stock units that will vest over time and increased his direct holdings to 45,815 shares. A footnote states that 15,067 of these are restricted stock units that vest over time and that on 5/21/26, 9,776 shares vested from a restricted stock unit award and he has deferred receipt of those shares.
HOWARD JULIE reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp director Julie Howard reported a compensation-related equity award. She received 15,067 shares of Common Stock in the form of a grant/award at $0.00 per share, increasing her directly held position to 48,165 shares after the transaction.
A footnote explains that these 15,067 shares are restricted stock units that will vest over time. It also notes that 9,776 shares from a prior restricted stock unit award vested on May 21, 2026, and Howard has deferred receipt of those shares.
MENDEZ ANGEL L reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp director Angel L. Mendez received an award of 15,067 shares of Common Stock in the form of restricted stock units at no cash cost. These units will vest over time. After this grant, he directly holds 37,515 shares of Sleep Number stock. A related footnote states that on 5/21/26, 9,776 shares vested from a prior restricted stock unit award and that he has deferred receipt of those vested shares, meaning he has chosen to receive them at a later date rather than immediately.
KILPATRICK DEBORAH L. reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp director Deborah L. Kilpatrick reported an equity compensation grant in the form of restricted stock units. She received 15,067 shares of Common Stock as a grant or award with no purchase price. These restricted stock units will vest over time according to the company’s schedule.
After this award, Kilpatrick now holds 27,571 shares of Sleep Number common stock directly. A footnote explains that on May 21, 2026, 9,776 shares from a prior restricted stock unit award vested and she has deferred receipt of those shares, meaning she has chosen to delay actually taking delivery of the stock.
Macadam Stephen E. reported acquisition or exercise transactions in this Form 4 filing.
Sleep Number Corp director Stephen E. Macadam reported receiving an equity award in the form of restricted stock units. He was granted 15,067 shares of Common Stock at no cost as a compensation-related award, bringing his directly held position to 127,572 shares after the transaction.
The footnote states that these 15,067 restricted stock units will vest over time. It also notes that on the same date, 9,776 shares from a prior restricted stock unit award vested and that he has deferred receipt of those shares, reinforcing that these are structured, non-market transactions.
Sleep Number Corp executive Amber Minson, EVP and Chief Marketing Officer, reported a routine share-withholding transaction related to equity compensation. On May 15, 2026, 7,242 shares of restricted stock vested, and 2,949 shares of common stock were withheld at $1.60 per share to cover estimated taxes. After this tax-withholding disposition, Minson directly owned 52,258 shares of common stock, along with 47,965 restricted stock units that are scheduled to vest over time. This filing reflects compensation and tax mechanics rather than an open-market sale.
Sleep Number Corporation reports a steep first-quarter loss and warns of substantial doubt about its ability to continue as a going concern. Net sales fell 19% year over year to $319 million as comparable retail sales dropped 16% and store traffic weakened. Gross margin compressed to 57.9% from 61.2%, and restructuring costs of $21.7 million, including $18 million of asset impairments tied to store and office closures, contributed to a net loss of $50.3 million, or $2.19 per share. The company ended the quarter with $1.5 million in cash, $606 million of borrowings under its credit facility and negative operating cash flow. A recent credit agreement amendment added a $25 million term loan and short-term covenant forbearance, but management does not expect to remain in compliance with covenants over the next 12 months and is exploring strategic and financing alternatives.
Sleep Number Corporation reported a weak first quarter 2026 as it continues a turnaround and capital structure review. Net sales were $319 million, down 18.9% year over year, reflecting lower volume and fewer stores. Gross profit fell to $185 million with margin compressing to 57.9% from 61.2% due to mix shift and discounting legacy inventory.
Operating expenses were $221 million, but on a non-GAAP basis fell 18% to $195 million after restructuring and other non‑recurring items, supported by about $200 million of annualized cost savings. Restructuring and other non‑recurring costs were $22 million. Net loss widened sharply to $50 million, or $2.19 per share, compared with a $9 million loss a year ago. Adjusted EBITDA dropped 74% to $6 million, a 1.8% margin. Liquidity remains tight: cash was $1.5 million and borrowings under the credit facility were $605.6 million, contributing to a shareholders’ deficit of $626 million and an Adjusted ROIC of ‑13.1%.
The company is executing a broad product and marketing reset and has completed its largest portfolio redesign in nearly a decade, reporting encouraging early customer response. It has secured covenant relief and $55 million of incremental liquidity, including a new $25 million term loan, and is working with advisors on strategic and financing options for a longer‑term capital solution while referencing going‑concern risks noted in its Form 10‑K and upcoming Form 10‑Q.
FMR LLC filed Amendment No. 1 to a Schedule 13G/A reporting ownership of Sleep Number Corp common stock. The filing states 105,412 shares beneficially owned, representing 0.5% of the class as of 03/31/2026. The cover lists sole dispositive power of 105,412 shares and shared voting power of 0. Signatures show authorization by Richard Bourgelas dated 05/05/2026 and reference a power of attorney effective April 13, 2026.